awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47950956-D32D52C7-E58A-44DE-9060-4C9379AD05B3
Q47950956-D32D52C7-E58A-44DE-9060-4C9379AD05B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47950956-D32D52C7-E58A-44DE-9060-4C9379AD05B3
The road from development to approval: evaluating the body of evidence to confirm biosimilarity.
P2860
Q47950956-D32D52C7-E58A-44DE-9060-4C9379AD05B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47950956-D32D52C7-E58A-44DE-9060-4C9379AD05B3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5ed1a33c25cdd29bec6f949dd79d141e7ea49ba6
P2860
Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data.